Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening

Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates from the National Health Interview Survey, and select issues related to cancer screening. In this 2018 update, we also summarize the new American Cancer Society colorectal cancer screening guideline and include a clarification in the language of the 2013 lung cancer screening guideline. CA Cancer J Clin 2018;68:297–316. © 2018 American Cancer Society.

[1]  E. Feuer,et al.  Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials , 2017, Annals of Internal Medicine.

[2]  Susan J. Curry,et al.  Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement , 2012, Annals of Internal Medicine.

[3]  L. Walter,et al.  Screening mammography in older women: a review. , 2014, JAMA.

[4]  E. Halm,et al.  Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk. , 2017, Preventive medicine.

[5]  Lori J Sokoll,et al.  Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. , 2014, Urology.

[6]  C. Flowers,et al.  Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.

[7]  E. Simões,et al.  Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States , 2015, Cancer medicine.

[8]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[9]  Aasma Shaukat,et al.  Long-term mortality after screening for colorectal cancer. , 2013, The New England journal of medicine.

[10]  D. Miglioretti,et al.  Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. , 2015, JAMA oncology.

[11]  D. Naidich,et al.  Screening for Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[12]  Gillian D Sanders,et al.  Benefits and Harms of Breast Cancer Screening: A Systematic Review. , 2015, JAMA.

[13]  D. Kopans,et al.  Digital Breast Tomosynthesis: State of the Art. , 2015, Radiology.

[14]  Jung-Han Kim,et al.  Stereotactic Core-Needle Biopsy of Non-Mass Calcifications: Outcome and Accuracy at Long-Term Follow-Up , 2003, Korean journal of radiology.

[15]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[16]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[17]  Ralf-Dieter Hilgers,et al.  Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  U. Ladabaum,et al.  Advanced‐Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  E. Meites,et al.  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. , 2016, MMWR. Morbidity and mortality weekly report.

[20]  S Kamen,et al.  The task force. , 1976, Journal of hospital dental practice.

[21]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[22]  P. Brousset,et al.  Sporadic Early-Onset Colorectal Cancer Is a Specific Sub-Type of Cancer: A Morphological, Molecular and Genetics Study , 2014, PloS one.

[23]  L. Rozek,et al.  Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[25]  A. Zauber,et al.  Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state‐of‐the‐science review , 2016, Cancer.

[26]  A. Zauber,et al.  The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline , 2018, Cancer.

[27]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[28]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[29]  D. Saslow,et al.  Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement , 2016, CA: a cancer journal for clinicians.

[30]  David C Whiteman,et al.  Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia , 2014, BMJ : British Medical Journal.

[31]  S. Fedewa,et al.  Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening , 2017, CA: a cancer journal for clinicians.

[32]  J. T. Cox,et al.  American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors , 2007, CA: a cancer journal for clinicians.

[33]  M. Parmar,et al.  Ovarian cancer screening: UKCTOCS trial – Authors' reply , 2016, The Lancet.

[34]  J. Baron,et al.  Patterns of Sociodemographic and Clinicopathologic Characteristics of Stages II and III Colorectal Cancer Patients by Age: Examining Potential Mechanisms of Young-Onset Disease , 2017, Journal of cancer epidemiology.

[35]  A. Jemal,et al.  Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States , 2017, JAMA internal medicine.

[36]  S. Altekruse,et al.  US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. , 2015, Journal of the National Cancer Institute.

[37]  Ahmedin Jemal,et al.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015 , 2017, JAMA oncology.

[38]  I. Thompson,et al.  Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision making. , 2014, JAMA.

[39]  D. Lieberman,et al.  Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice , 2005, Annals of Internal Medicine.

[40]  A. Moscicki,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2002, CA: a cancer journal for clinicians.

[41]  Matthew Burnell,et al.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) , 2009, Journal of Family Planning and Reproductive Health Care.

[42]  R. Yantiss,et al.  Early‐onset Colorectal Cancer is Distinct From Traditional Colorectal Cancer , 2017, Clinical colorectal cancer.

[43]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[44]  Mara A Schonberg,et al.  Prognostic indices for older adults: a systematic review. , 2012, JAMA.

[45]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[46]  J. Gohagan,et al.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.

[47]  Douglas K Owens,et al.  Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[48]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[49]  J. Habbema,et al.  Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. , 2014, Annals of internal medicine.

[50]  D. Ahnen,et al.  The increasing incidence of young-onset colorectal cancer: a call to action. , 2014, Mayo Clinic proceedings.

[51]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[52]  W. P. Evans,et al.  American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 , 2003, CA: a cancer journal for clinicians.

[53]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[54]  D. Mccrory,et al.  Evidence-Based Clinical Practice Guidelines Medical Therapy For Pulmonary Arterial Hypertension : ACCP , 2004 .

[55]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .

[56]  David Chia,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[57]  P. Scardino,et al.  The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. , 2016, Urology.

[58]  C. Klabunde,et al.  National Evidence on the Use of Shared Decision Making in Prostate-Specific Antigen Screening , 2013, The Annals of Family Medicine.

[59]  H. D. de Koning,et al.  The impact of PLCO control arm contamination on perceived PSA screening efficacy , 2012, Cancer Causes & Control.

[60]  Christopher D. Jensen,et al.  Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis , 2017, JAMA.

[61]  O. Brawley,et al.  Cancer screening in the United States, 2012 , 2012, CA: a cancer journal for clinicians.

[62]  M. Schiffman,et al.  2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors , 2013, Journal of lower genital tract disease.

[63]  D. Oram,et al.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial , 2016, The Lancet.

[64]  Colorectal Cancer Screening in Average-Risk Adults , 2019, Annals of Internal Medicine.

[65]  Heber MacMahon,et al.  The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. , 2012, The Journal of thoracic and cardiovascular surgery.

[66]  Douglas K Rex,et al.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.

[67]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[68]  David Rind,et al.  GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. , 2013, Journal of clinical epidemiology.

[69]  Charles J. Kahi,et al.  Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus Update by the American Cancer Society and US Multi‐Society Task Force on Colorectal Cancer * † , 2006, CA: a cancer journal for clinicians.

[70]  A. Jemal,et al.  Breast cancer statistics, 2017, racial disparity in mortality by state , 2017, CA: a cancer journal for clinicians.

[71]  Matthew B Schabath,et al.  Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[72]  F. François,et al.  Colorectal cancer screening of high-risk populations: A national survey of physicians , 2012, BMC Research Notes.

[73]  Robert H Fletcher,et al.  Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi‐Society Task Force on Colorectal Cancer and the American Cancer Society * , † , 2006, Gastroenterology.

[74]  Charles J. Kahi,et al.  Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. , 2016, Gastroenterology.

[75]  S. Fedewa,et al.  Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening , 2015, CA: a cancer journal for clinicians.

[76]  Christopher D. Jensen,et al.  Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests , 2017, Annals of Internal Medicine.

[77]  A. Jemal,et al.  Colorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014 , 2017, JAMA.

[78]  Brian J Zikmund-Fisher,et al.  Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). , 2009, Archives of internal medicine.

[79]  Jennifer L. Lund,et al.  Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population‐based Screening , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[80]  P. Goodfellow,et al.  Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer , 2017, JAMA oncology.

[81]  M. Schiffman,et al.  Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. , 2014, Journal of the National Cancer Institute.

[82]  K. Hughes,et al.  Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  Diane Solomon,et al.  2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. , 2013, Obstetrics and gynecology.

[84]  Philip S Rosenberg,et al.  Colorectal Cancer Incidence Patterns in the United States, 1974–2013 , 2017, Journal of the National Cancer Institute.

[85]  D. Gertig,et al.  Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study , 2013, BMC Medicine.

[86]  Matthew Burnell,et al.  Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  David Lieberman,et al.  Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. , 2017, Gastroenterology.

[88]  D. Ransohoff,et al.  New American Cancer Society process for creating trustworthy cancer screening guidelines. , 2011, JAMA.

[89]  J. Church,et al.  Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer , 2014, The American Journal of Gastroenterology.

[90]  A. D'Amico,et al.  American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.

[91]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[92]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[93]  V. Moyer,et al.  Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement , 2012, Annals of Internal Medicine.

[94]  E. J. Mayeaux,et al.  Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. , 2015, Gynecologic oncology.

[95]  L. Svenson,et al.  Effect of human papillomavirus vaccination on cervical cancer screening in Alberta , 2016, Canadian Medical Association Journal.

[96]  T. Johnson,et al.  Accuracy of Self-Reported Cancer-Screening Histories: A Meta-analysis , 2008, Cancer Epidemiology Biomarkers & Prevention.

[97]  Ziding Feng,et al.  Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. , 2006, Journal of the National Cancer Institute.

[98]  L. Solberg,et al.  Health Benefits and Cost-Effectiveness of Brief Clinician Tobacco Counseling for Youth and Adults , 2017, The Annals of Family Medicine.

[99]  Clare Gilham,et al.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials , 2014, The Lancet.

[100]  Jonathan E. Shoag,et al.  Reevaluating PSA Testing Rates in the PLCO Trial. , 2016, The New England journal of medicine.

[101]  S. Chiou,et al.  Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers , 2017, Journal of the National Cancer Institute.

[102]  B. Levin,et al.  Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers , 2003, CA: a cancer journal for clinicians.

[103]  J. Lortet-Tieulent,et al.  Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening , 2016, CA: a cancer journal for clinicians.

[104]  E. Halm,et al.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems , 2016, Cancer Epidemiology, Biomarkers and Prevention.

[105]  N. Hyman,et al.  Rectal cancer in patients under the age of 50 years: the delayed diagnosis. , 2016, American journal of surgery.

[106]  Greta M. Massetti,et al.  Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement , 2017, American journal of respiratory and critical care medicine.

[107]  M. Schiffman,et al.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012, CA: a cancer journal for clinicians.

[108]  A. Jemal,et al.  Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[109]  S. J. Henley,et al.  Human Papillomavirus-Associated Cancers - United States, 2008-2012. , 2016, MMWR. Morbidity and mortality weekly report.